ASX:VHT

Volpara Health Technologies Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume434,964 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Volpara Health Technologies (ASX:VHT) Vs. BUX, IME, BD1, CRL, CTE, and DVL

Should you be buying VHT stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to Volpara Health Technologies, including (BUX) (BUX), 12144 (IME), BARD1 Life Sciences (BD1), Charles River Laboratories International (CRL), Cryosite (CTE), and dorsaVi (DVL).

Volpara Health Technologies (ASX:VHT) and (BUX) (CNSX:BUX) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, institutional ownership and profitability.

Valuation and Earnings

This table compares Volpara Health Technologies and (BUX)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Volpara Health Technologies$15.22 million0.00$-21,336,615.68A($0.09)N/A
(BUX)N/AN/AN/AN/AN/A

(BUX) has lower revenue, but higher earnings than Volpara Health Technologies.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Volpara Health Technologies and (BUX), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Volpara Health Technologies0000N/A
(BUX)0000N/A

Profitability

This table compares Volpara Health Technologies and (BUX)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Volpara Health TechnologiesN/AN/AN/A
(BUX)N/AN/AN/A

Summary

Volpara Health Technologies beats (BUX) on 1 of the 1 factors compared between the two stocks.

12144 (CNSX:IME) and Volpara Health Technologies (ASX:VHT) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, valuation, earnings and risk.

Valuation and Earnings

This table compares 12144 and Volpara Health Technologies' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
12144N/AN/AN/AN/AN/A
Volpara Health Technologies$15.22 million0.00$-21,336,615.68A($0.09)N/A

12144 has higher earnings, but lower revenue than Volpara Health Technologies.

Analyst Recommendations

This is a breakdown of current recommendations for 12144 and Volpara Health Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
121440000N/A
Volpara Health Technologies0000N/A

Profitability

This table compares 12144 and Volpara Health Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
12144N/AN/AN/A
Volpara Health TechnologiesN/AN/AN/A

Summary

Volpara Health Technologies beats 12144 on 1 of the 1 factors compared between the two stocks.

BARD1 Life Sciences (ASX:BD1) and Volpara Health Technologies (ASX:VHT) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, analyst recommendations, earnings and risk.

Profitability

This table compares BARD1 Life Sciences and Volpara Health Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BARD1 Life SciencesN/AN/AN/A
Volpara Health TechnologiesN/AN/AN/A

Earnings and Valuation

This table compares BARD1 Life Sciences and Volpara Health Technologies' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BARD1 Life Sciences$612,251.000.00$-6,644,706.43A($0.08)N/A
Volpara Health Technologies$15.22 million0.00$-21,336,615.68A($0.09)N/A

BARD1 Life Sciences has higher earnings, but lower revenue than Volpara Health Technologies.

Analyst Recommendations

This is a summary of recent ratings and target prices for BARD1 Life Sciences and Volpara Health Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BARD1 Life Sciences0000N/A
Volpara Health Technologies0000N/A

Summary

BARD1 Life Sciences beats Volpara Health Technologies on 2 of the 3 factors compared between the two stocks.

Charles River Laboratories International (CNSX:CRL) and Volpara Health Technologies (ASX:VHT) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Profitability

This table compares Charles River Laboratories International and Volpara Health Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Charles River Laboratories InternationalN/AN/AN/A
Volpara Health TechnologiesN/AN/AN/A

Valuation and Earnings

This table compares Charles River Laboratories International and Volpara Health Technologies' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charles River Laboratories InternationalN/AN/AN/AN/AN/A
Volpara Health Technologies$15.22 million0.00$-21,336,615.68A($0.09)N/A

Charles River Laboratories International has higher earnings, but lower revenue than Volpara Health Technologies.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Charles River Laboratories International and Volpara Health Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Charles River Laboratories International0000N/A
Volpara Health Technologies0000N/A

Summary

Volpara Health Technologies beats Charles River Laboratories International on 1 of the 1 factors compared between the two stocks.

Cryosite (ASX:CTE) and Volpara Health Technologies (ASX:VHT) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Cryosite and Volpara Health Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cryosite0000N/A
Volpara Health Technologies0000N/A

Profitability

This table compares Cryosite and Volpara Health Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CryositeN/AN/AN/A
Volpara Health TechnologiesN/AN/AN/A

Valuation and Earnings

This table compares Cryosite and Volpara Health Technologies' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cryosite$9.71 million0.00$515,455.60A$0.01N/A
Volpara Health Technologies$15.22 million0.00$-21,336,615.68A($0.09)N/A

Cryosite has higher earnings, but lower revenue than Volpara Health Technologies.

Summary

Cryosite beats Volpara Health Technologies on 2 of the 3 factors compared between the two stocks.

dorsaVi (ASX:DVL) and Volpara Health Technologies (ASX:VHT) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation.

Analyst Ratings

This is a summary of current recommendations for dorsaVi and Volpara Health Technologies, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
dorsaVi0000N/A
Volpara Health Technologies0000N/A

Profitability

This table compares dorsaVi and Volpara Health Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
dorsaViN/AN/AN/A
Volpara Health TechnologiesN/AN/AN/A

Valuation and Earnings

This table compares dorsaVi and Volpara Health Technologies' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
dorsaVi$1.65 million0.00$-3,158,396.93A($0.01)N/A
Volpara Health Technologies$15.22 million0.00$-21,336,615.68A($0.09)N/A

dorsaVi has higher earnings, but lower revenue than Volpara Health Technologies.

Summary

dorsaVi beats Volpara Health Technologies on 2 of the 3 factors compared between the two stocks.


Volpara Health Technologies Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
BUX
(BUX)
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Gap Up
IME
12144
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
BD1
BARD1 Life Sciences
0.5N/AN/A$0.00$612,251.000.00High Trading Volume
Gap Up
CRL
Charles River Laboratories International
0.5N/AN/A$0.00N/A0.00Gap Up
CTE
Cryosite
0.6N/AN/A$0.00$9.71 million0.00High Trading Volume
Gap Up
DVL
dorsaVi
0.5N/AN/A$0.00$1.65 million0.00High Trading Volume
Gap Up
Epigenomics logo
EPGNY
Epigenomics
0.6$12.39flat$0.00N/A0.00News Coverage
ETAH
Eternity Healthcare
0.6$0.00flat$0.00N/A0.00High Trading Volume
Gap Up
GSS
Genetic Signatures
0.0N/AN/A$0.00$29.13 million0.00High Trading Volume
GTG
Genetic Technologies
0.0N/AN/A$0.00$25,714.000.00High Trading Volume
IBX
Imagion Biosystems
0.6N/AN/A$0.00$2.70 million0.00High Trading Volume
Gap Up
IDX
Integral Diagnostics
0.8N/AN/A$0.00$314.82 million0.00High Trading Volume
Gap Up
LSH
Lifespot Health
0.5N/AN/A$0.00$22,127.000.00High Trading Volume
Gap Up
MEDD
Medical Imaging
0.4$0.01flat$0.00N/A0.00
OSL
OncoSil Medical
0.5N/AN/A$0.00$2.22 million0.00High Trading Volume
Gap Up
Parallax Health Sciences logo
PRLX
Parallax Health Sciences
0.5$0.01flat$0.00N/A0.00
RHY
Rhythm Biosciences
0.0N/AN/A$0.00$1.21 million0.00High Trading Volume
Sartorius Aktiengesellschaft logo
SRT3
Sartorius Aktiengesellschaft
0.6$462.50flat$0.00N/A0.00High Trading Volume
SENS
Senseonics
0.0N/AN/A$0.00$4.95 million0.00High Trading Volume
SENS
Senseonics
0.0N/AN/A$0.00N/A0.00High Trading Volume
Siemens Healthineers logo
SMMNY
Siemens Healthineers
0.5$29.28flat$0.00N/A0.00
SIL
Smiles Inclusive
0.4N/AN/A$0.00$36.48 million0.00High Trading Volume
Gap Up
OBJ
Wellfully Limited (OBJ.AX)
0.0N/AN/A$0.00$1.48 million0.00High Trading Volume
WUXIF
WuXi AppTec
1.0$19.88flat$0.00N/A0.00
This page was last updated on 4/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.